Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia

Autor: Serena Barozzi, Giuseppe Loffredo, Carlo L. Balduini, Chiara Gnan, Alessandra Balduini, Caterina Marconi, Michael Doubek, Lenka Radová, Christian A. Di Buduo, Federica Melazzini, Caterina Alfano, Anna Savoia, Daniela De Rocco, Valeria Bozzi, Tommaso Pippucci, Flavia Palombo, Marco Seri, Michela Faleschini, Katerina Stano Kozubik, Patrizia Noris, Šárka Pospíšilová, Alessandro Pecci
Přispěvatelé: Melazzini, Federica, Palombo, Flavia, Balduini, Alessandra, DE ROCCO, Daniela, Marconi, Caterina, Noris, Patrizia, Gnan, Chiara, Pippucci, Tommaso, Bozzi, Valeria, Faleschini, Michela, Barozzi, Serena, Doubek, Michael, Di Buduo, Christian A., Kozubik, Katerina Stano, Radova, Lenka, Loffredo, Giuseppe, Pospisilova, Sarka, Alfano, Caterina, Seri, Marco, Balduini, Carlo L., Pecci, Alessandro, Savoia, Anna, De Rocco, Daniela, Di Buduo, Christian A, Stano Kozubik, Katerina, Balduini, Carlo L
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Fibrinogen
0302 clinical medicine
hemic and lymphatic diseases
Medicine
Platelet
platelet disorders
inherited thrombocytopenia
Child
inherited thrombocytopenias
education.field_of_study
Hematology
Incidence (epidemiology)
Nuclear Proteins
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Pedigree
3. Good health
Cell Transformation
Neoplastic

Child
Preschool

Core Binding Factor Alpha 2 Subunit
Cohort
Intercellular Signaling Peptides and Proteins
medicine.drug
Adult
Platelets
medicine.medical_specialty
Adolescent
Platelet disorder
Population
Article
Young Adult
03 medical and health sciences
Internal medicine
Humans
Family
Genetic Predisposition to Disease
education
Proto-Oncogene Proteins c-ets
business.industry
Infant
Newborn

Infant
Thrombocytopenia
Repressor Proteins
ETV6
030104 developmental biology
Mutation
Immunology
business
030215 immunology
Zdroj: Melazzini, F, Palombo, F, Balduini, A, De Rocco, D, Marconi, C, Noris, P, Gnan, C, Pippucci, T, Bozzi, V, Faleschini, M, Barozzi, S, Doubek, M, Di Buduo, C A, Stano Kozubik, K, Radova, L, Loffredo, G, Pospisilova, S, Alfano, C, Seri, M, Balduini, C L, Pecci, A & Savoia, A 2016, ' Clinical and pathogenetic features of ETV6 related thrombocytopenia with predisposition to acute lymphoblastic leukemia ', Haematologica . https://doi.org/10.3324/haematol.2016.147496
Popis: ETV6-related thrombocytopenia is an autosomal dominant thrombocytopenia that has been recently identified in a few families and has been suspected to predispose to hematologic malignancies. To gain further information on this disorder, we searched for ETV6 mutations in the 130 families with inherited thrombocytopenia of unknown origin from our cohort of 274 consecutive pedigrees with familial thrombocytopenia. We identified 20 patients with ETV6-related thrombocytopenia from seven pedigrees. They have five different ETV6 variants, including three novel mutations affecting the highly conserved E26 transformation-specific domain. The relative frequency of ETV6-related thrombocytopenia was 2.6% in the whole case series and 4.6% among the families with known forms of inherited thrombocytopenia. The degree of thrombocytopenia and bleeding tendency of the patients with ETV6-related thrombocytopenia were mild, but four subjects developed B-cell acute lymphoblastic leukemia during childhood, resulting in a significantly higher incidence of this condition compared to that in the general population. Clinical and laboratory findings did not identify any particular defects that could lead to the suspicion of this disorder from the routine diagnostic workup. However, at variance with most inherited thrombocytopenias, platelets were not enlarged. In vitro studies revealed that the maturation of the patients' megakaryocytes was defective and that the patients have impaired proplatelet formation. Moreover, platelets from patients with ETV6-related thrombocytopenia have reduced ability to spread on fibrinogen. Since the dominant thrombocytopenias due to mutations in RUNX1 and ANKRD26 are also characterized by normal platelet size and predispose to hematologic malignancies, we suggest that screening for ETV6, RUNX1 and ANKRD26 mutations should be performed in all subjects with autosomal dominant thrombocytopenia and normal platelet size.
Databáze: OpenAIRE